Press release
Xerostomia Therapeutics Market Outlook and Analysis to 2026 – Leading Top Companies are Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline, OraHealth, OraPharma, Parnell Pharmaceuticals
The Report focuses on Xerostomia Therapeutics Market Asia Pacific Market, especially in China, Japan, Taiwan, Korea, Southeast Asia, India and Australia. As well as United Kingdom.The Global Xerostomia Therapeutics Market Size is anticipated to reach over USD 822.14 million by 2026 according to a new research published by Polaris Market Research.
Xerostomia is also defined as dry mouth condition causing due to absent or reduced saliva. In general, xerostomia is not considered as a disorder, but it is a condition with symptom associated with various medical situations such as a side effect of a radioactivity to the head and neck generally during chemotherapy or a side effect of a number of medications. It may or may not be associated with decreased salivary gland function. Xerostomia is a common problem majorly observed in geriatric population affecting around 20% of the individuals. However, xerostomia does not act to be age-related disorder itself as xerostomia is generally caused as a side effect.
Download PDF Sample Report: https://bit.ly/2T9hIC7
The rise in favorable reimbursement scenario for xerostomia products and growing awareness about related with ailments are the major factors contributing the global xerostomia therapeutics market growth. Moreover, growing occurrence of xerostomia and related diseases such as hypertension, Parkinson’s disease, Sjogren’s syndrome, and diabetes has an affirmative influence on the global market. According to the industry reports, approximately 25 million individuals in the U.S. experience dry mouth. Moreover, according to Sjogren Syndrome Foundation of America, approximately 4 million Americans are suffering Sjogren’s syndrome. Rising resourcefulness for the growth of awareness regarding xerostomia another factors expected to drive the market growth. For instance, Sjogren Syndrome Foundation of America conducts wakefulness programs to support people suffering the syndrome in North America. In addition, the foundation introduced the ‘5-Year Breakthrough Goal’ in 2012 with an object to cure the xerostomia as well as decrease the time required to analyze it. Moreover, key players are focusing on acquiring developing establishments and conduct lineups to increase consciousness regarding xerostomia, further enhancing the global xerostomia therapeutics market growth significantly.
The global Xerostomia Therapeutics Market is segmented on the basis of product, distribution channel, and geography.
On the basis of product, the global xerostomia therapeutics market is segmented into Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen. On the basis of products, dentifrices segment is estimated to dominate the market. The dominance is primarily due to affordability, availability, effectiveness, higher adoption amongst the users. On the basis of the distribution channel, the global xerostomia therapeutics market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. In 2017, the hospital pharmacy is anticipated to dominate the market. The dominance of hospital pharmacy is majorly due to the availability of limited branded drugs, safety & efficacy, safety, and low pricing of products. Asia Pacific is anticipated to make a dominating growth for Xerostomia Therapeutics Market during the forecast period. growing healthcare spending, the rise in inventiveness for growing awareness, and increasing occurrence of ailments such as Parkinson’s disease, diabetes, cancer, and HIV causing dry mouth conditions and factors estimated to bolster the xerostomia therapeutics market in the Asia Pacific.
Some major key players in global Xerostomia Therapeutics Market include Eisai Inc., Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline plc, Mission Pharmacal Company, OraHealth Inc., OraPharma, Inc., Parnell Pharmaceuticals, Inc., Saliwell Ltd., and Sun Pharmaceutical Industries among others.
For More Information and TOC: https://bit.ly/2qIRbhO
About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: neel@polarismarketresearch.com
Web: https://www.polarismarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Xerostomia Therapeutics Market Outlook and Analysis to 2026 – Leading Top Companies are Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline, OraHealth, OraPharma, Parnell Pharmaceuticals here
News-ID: 1364826 • Views: …
More Releases from Polaris Market Research & Consulting

Advanced Energy Storage Systems Market Set for Growth: Expected to Reach USD 46. …
𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐄𝐧𝐞𝐫𝐠𝐲 𝐒𝐭𝐨𝐫𝐚𝐠𝐞 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
The advanced energy storage systems market size was valued at USD 18.44 billion in 2024. It is projected to grow to USD 46.31 billion by 2034, exhibiting a compound annual growth rate of 9.7% from 2025 to 2034.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:
Advanced energy storage is usually a battery that utilizes a smart energy management system to charge and discharge as required. Usually, AES is positioned as a culmination load-shaving…

Activated Alumina Market on the Rise: Projected 5.7% CAGR Growth to USD 2,035.96 …
𝐀𝐜𝐭𝐢𝐯𝐚𝐭𝐞𝐝 𝐀𝐥𝐮𝐦𝐢𝐧𝐚 𝐌𝐚𝐫𝐤𝐞𝐭
𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:
The global activated alumina market was valued at USD 1,175.56 million in 2024 and is expected to grow to USD 2,035.96 million by 2034. The market is expected to expand at a CAGR of 5.7% from 2025 to 2034.
𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Activated alumina is a poros, solid configuration of aluminum oxide, in other respects, acknowledged as alumina. This is the similar mineral that constitutes the valuable gems ruby and…

Global Jewelry Market Projected to Reach $494.89 Billion by 2032
𝐓𝐡𝐞 𝐣𝐞𝐰𝐞𝐥𝐫𝐲 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟐𝟓𝟔.𝟖𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. 𝐈𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 𝟒𝟗𝟒.𝟖𝟗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 𝐨𝐟 𝟕.𝟔% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:
Jewelry is a unique bauble such as a ring, bracelet, necklace, or any other commodity rendered from jewels, valuable metals, or any other substance. Presently, the word jewelry is utilized to narrate any item of…

Projected Growth Personal Cloud Market to Hit USD 158.17 Billion By 2032, Growin …
𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥 𝐂𝐥𝐨𝐮𝐝 𝐌𝐚𝐫𝐤𝐞𝐭
𝐓𝐡𝐞 𝐬𝐢𝐳𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥 𝐜𝐥𝐨𝐮𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟐𝟗.𝟔𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟑𝟓.𝟓𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 𝐭𝐨 𝐔𝐒𝐃 𝟏𝟓𝟖.𝟏𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐝𝐞𝐦𝐨𝐧𝐬𝐭𝐫𝐚𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟐𝟎.𝟓𝟗% 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧
A personal cloud refers to a digital space where an individual can store, access, and manage their data, like photos, documents, and videos, across multiple devices…
More Releases for Xerostomia
Xerostomia (Dry Mouth) Therapeutics Market Opportunities, Business Statistics Re …
The global xerostomia therapeutics market size is expected to reach USD 822.1 million by 2026 growing at a CAGR of 3.6% during the forecast period according to a new report published by Polaris Market Research.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=31976
Some of the leading companies in this market include Colgate-Palmolive Company, EUSA Pharma, GlaxoSmithKline plc, Forward Science, Mission Pharmacal Company, Eisai Inc., Ora Health Inc., Parnell Pharmaceuticals, Inc., Ora…
Global Xerostomia (Dry Mouth) Treatment Market Segmentation and Analysis Researc …
With recorded sales worth US$ 952.7 Bn in 2021, the global xerostomia (dry mouth) treatment market is expected to experience high growth over the coming years owing to increasing consumption of prescribed medicines globally. The xerostomia treatment market is estimated to expand at a CAGR of nearly 6.1% from 2022 to 2032.
Xerostomia is commonly known as dry mouth that occurs as a result of decreased or missing saliva because of…
Xerostomia Therapeutics Market Size - Forecasts to 2026
As per the research conducted by GME, the Xerostomia Therapeutics Market will grow with a CAGR value of 3.8 percent by 2026. Factors boosting demand growth include increasing prescription drug consumption, quick accessibility & cost-effectiveness of drugs, a rising elderly population demographic, and an uptick in the incidence of disorders such as Sjogren's syndrome, HIV, diabetes, and Alzheimer's disease, among others.
Browse 151 Market Data Tables and 111 Figures spread through…
Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027
"Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Xerostomia epidemiology and market outlook for the 7MM.
Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Xerostomia Understanding and Treatment Algorithm
The market report provides the overview of the Xerostomia by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches…
Xerostomia Market: Global Market Capacity, Production, Revenue by Regions till 2 …
Xerostomia Market report gives a far reaching investigation of the Xerostomia the Research of disease transmission, giving the chronicled and forecasted information for the 7MM during the estimate time frame from 2016-2027. The report covers detailed overview of Xerostomia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns, it also helps to recognize the growth opportunities in the 7MM with respect to the patient population.
Get Sample PDF of Xerostomia…
Xerostomia (Dry Mouth) Treatment Market Growth to be Stimulated by 2025
Xerostomia, commonly known as dry mouth, is defined as a condition resulting in the limited production of saliva or alteration in the saliva quality to retain the mouth wet. Xerostomia is normally caused due to a variety of factors such as side-effects from medication, dehydration, surgery, mouth bleeding, smoking, and irradiation of neck and head. The xerostomia is not classified as a disease but as symptoms of variable disorders. Xerostomia…